166 related articles for article (PubMed ID: 2423867)
21. Recombinant human IL-1 alpha and -1 beta potentiate IgE-mediated histamine release from human basophils.
Massey WA; Randall TC; Kagey-Sobotka A; Warner JA; MacDonald SM; Gillis S; Allison AC; Lichtenstein LM
J Immunol; 1989 Sep; 143(6):1875-80. PubMed ID: 2476485
[TBL] [Abstract][Full Text] [Related]
22. Activation of protein kinase C by selective binding of arginine-rich polypeptides.
Leventhal PS; Bertics PJ
J Biol Chem; 1993 Jul; 268(19):13906-13. PubMed ID: 8390981
[TBL] [Abstract][Full Text] [Related]
23. Increases in cytosolic Ca2+ accompany basophil activation by eosinophil granule major basic protein.
MacGlashan DW; Gleich GJ; Thomas LL
Immunol Lett; 1997 Jun; 58(1):37-42. PubMed ID: 9436467
[TBL] [Abstract][Full Text] [Related]
24. Adenosine inhibits and potentiates IgE-dependent histamine release from human basophils by an A2-receptor mediated mechanism.
Church MK; Holgate ST; Hughes PJ
Br J Pharmacol; 1983 Dec; 80(4):719-26. PubMed ID: 6085948
[TBL] [Abstract][Full Text] [Related]
25. Fenoterol, a selective beta 2-adrenergic agonist, and inhibition of IgE-mediated basophil histamine release.
Morita Y; Miyamoto T
Allergy; 1987 Oct; 42(7):524-8. PubMed ID: 2446520
[TBL] [Abstract][Full Text] [Related]
26. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors.
Liu MC; Proud D; Lichtenstein LM; MacGlashan DW; Schleimer RP; Adkinson NF; Kagey-Sobotka A; Schulman ES; Plaut M
J Immunol; 1986 Apr; 136(7):2588-95. PubMed ID: 2419444
[TBL] [Abstract][Full Text] [Related]
27. Effects of protamine on histamine release from human lung.
Levy JH; Faraj BA; Zaidan JR; Camp VM
Agents Actions; 1989 Aug; 28(1-2):70-2. PubMed ID: 2476923
[TBL] [Abstract][Full Text] [Related]
28. The human recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule.
Wantke F; MacGlashan DW; Langdon JM; MacDonald SM
J Allergy Clin Immunol; 1999 Apr; 103(4):642-8. PubMed ID: 10200014
[TBL] [Abstract][Full Text] [Related]
29. Influence of bacterial endotoxins on basophil histamine release. Potentiation of antigen- and bacteria-induced histamine release.
Norn S; Baek L; Jensen C; Skov PS; Permin H; Jarløv JO; Koch C
Allergy; 1986 Feb; 41(2):125-30. PubMed ID: 2422974
[TBL] [Abstract][Full Text] [Related]
30. Assessment of histamine release from basophils in whole blood by benzylpenicilloyl poly-L-lysine in penicillin-sensitized patients.
Koller DY; Rosenkranz AR; Pirker C; Götz M; Jarisch R
Allergy; 1992 Oct; 47(5):459-62. PubMed ID: 1283059
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of human basophil histamine release by interleukin 5.
Hirai K; Yamaguchi M; Misaki Y; Takaishi T; Ohta K; Morita Y; Ito K; Miyamoto T
J Exp Med; 1990 Nov; 172(5):1525-8. PubMed ID: 1700056
[TBL] [Abstract][Full Text] [Related]
32. Effect of antibiotics on immediate hypersensitivity reactions in vitro: suppression of IgE-mediated histamine release from peripheral blood basophils by fosfomycin.
Ida S; Shindoh Y; Takishima T
Microbiol Immunol; 1987; 31(10):975-84. PubMed ID: 2448594
[TBL] [Abstract][Full Text] [Related]
33. Regulation of human basophil activation; the role of Na+ and Ca2+ in IL-3-induced potentiation of IgE-mediated histamine release from human basophils.
Beauvais F; Echasserieau K; Burtin C; Benveniste J
Clin Exp Immunol; 1994 Jan; 95(1):191-4. PubMed ID: 7507013
[TBL] [Abstract][Full Text] [Related]
34. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables.
MacGlashan DW
J Allergy Clin Immunol; 1993 Feb; 91(2):605-15. PubMed ID: 7679683
[TBL] [Abstract][Full Text] [Related]
35. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions.
Piliponsky AM; Pickholtz D; Gleich GJ; Levi-Schaffer F
J Allergy Clin Immunol; 2001 Jun; 107(6):993-1000. PubMed ID: 11398076
[TBL] [Abstract][Full Text] [Related]
36. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol.
Marone G; Ambrosio G; Bonaduce D; Genovese A; Triggiani M; Condorelli M
Int Arch Allergy Appl Immunol; 1984; 74(4):356-61. PubMed ID: 6203844
[TBL] [Abstract][Full Text] [Related]
39. Comparison of basophil histamine release, eosinophil cationic protein and non-specific airway responsiveness between mite-sensitive asthmatic and non-asthmatic children and non-allergic controls.
Takeda K; Shibasaki M; Imoto N; Shimakura Y; Takita H
Clin Exp Allergy; 1996 Aug; 26(8):918-25. PubMed ID: 8877157
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin.
Marone G; Columbo M; Triggiani M; Cirillo R; Genovese A; Formisano S
Biochem Pharmacol; 1987 Jan; 36(1):13-20. PubMed ID: 2432900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
